Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Okyo Pharma Limited ADR (OKYO)

Okyo Pharma Limited ADR (OKYO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
News & Headlines for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited

BALTIMORE, MD / ACCESS Newswire / January 30, 2025 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a...

OKYO : 1.3500 (+7.14%)
S&P Futures Climb Ahead of Key U.S. PPI Data, ECB Decision in Focus

September S&P 500 futures (ESU23) are trending up +0.29% this morning after three major U.S. benchmark indices ended the regular session mixed as investors digested the latest U.S. inflation report while...

ESU23 : 4,491.72s (-0.32%)
MRNA : 32.66 (+0.65%)
JBHT : 148.55 (+0.72%)
F : 10.00 (-0.10%)
AAL : 11.39 (+1.15%)
ADBE : 387.26 (-0.60%)
CPRT : 53.63 (-0.41%)
LEN : 115.22 (-4.04%)
ROO.L.EB : 122.700 (-1.05%)
SMTC : 39.62 (-2.51%)
PCT : 7.77 (+1.83%)
MET : 82.36 (-0.44%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.3500 (+7.14%)
ALC : 90.56 (-0.89%)
BLCO : 15.56 (-1.21%)
JNJ : 163.63 (+0.37%)
RHHBY : 43.7000 (+0.64%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.3500 (+7.14%)
ALC : 90.56 (-0.89%)
BLCO : 15.56 (-1.21%)
JNJ : 163.63 (+0.37%)
RHHBY : 43.7000 (+0.64%)
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

OKYO : 1.3500 (+7.14%)
OKYO.LN : 1.400 (-24.32%)
NVS : 112.13 (-0.95%)
ALDX : 6.58 (-2.08%)
OCUL : 7.51 (+0.94%)
EYPT : 6.25 (+2.46%)
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments

/PRNewswire/ -- The Global Dry Eye Syndrome market is witnessing continued growth due to the factors such as the growing demand for effective treatments, the...

OKYO : 1.3500 (+7.14%)
NVS : 112.13 (-0.95%)
ALDX : 6.58 (-2.08%)
OCUL : 7.51 (+0.94%)
EYPT : 6.25 (+2.46%)
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, plans a Q4 2022...

OKYO : 1.3500 (+7.14%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited - PDMR Dealing

LONDON and NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a bio-pharmaceutical company focused on developing...

OKYO : 1.3500 (+7.14%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited - PDMR Dealing

LONDON and BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a life sciences company focused on the discovery and...

OKYO : 1.3500 (+7.14%)
EMMLF : 0.0137 (-32.51%)
OKYO.LN : 1.400 (-24.32%)
OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing

LONDON, May 19, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a life sciences company focused...

OKYO : 1.3500 (+7.14%)
EMMLF : 0.0137 (-32.51%)
OKYO.LN : 1.400 (-24.32%)

Barchart Exclusives

Nvidia CEO Jensen Huang Is Betting on $1 Trillion in Data Center Buildouts By 2028. Here’s the Top Stock to Buy.
The stock of Nvidia’s only genuine competitor could benefit from the upcoming data center boom. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals